WHO vaccine-preventable diseases: monitoring system. 2017 global summary

Last updated 31-July-2017 (data as of 19-July-2017)
Next overall update Fall-2017
EPI mother and child logo         
Select a country

Development status: Developed economy GNI / capita (US$): 18'4801 Infant (under 12 months) mortality rate: 22
GDP / capita (US$): 28'0951 Child (under 5 years) mortality rate: 32

Population data in thousands3

  2016  2015  2014  2013  2012  2000  1990  1980 
Total population 1'312  1'315  1'318  1'322  1'325  1'399  1'565  1'474 
Births 14  14  14  14  15  13  21  22 
Surviving infants 14  14  14  14  15  13  20  22 
Pop. less than 5 years 68  71  73  75  77  61  119  109 
Pop. less than 15 years 213  212  210  207  206  246  347  319 
Female 15-49 years 287  291  295  300  306  348  380  372 

Number of reported cases

(Click for retrospective incidence data for Estonia)
Diphtheria
ChartChart
 
Japanese encephalitis
 
Measles
ChartChart ChartChart
  33 
Mumps
ChartChart
  10  12  63 
Pertussis
ChartChart
  74  77  43  55  149  503  87 
Polio*
ChartChart
 
Rubella
ChartChart
  370 
Rubella (CRS)
ChartChart
 
Tetanus (neonatal)
ChartChart
 
Tetanus (total)**
ChartChart
 
Yellow fever
 
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For disaggregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Estonia)
Vaccine year result method % card seen                                                
BCG          95  95  95  96  97  99* 
DTP1          95  94  95  96  96  96 
DTP3          93  93  93  94  94  93 
DTP4          91  92  92 
IPV1          95  95  95 
HepB_BD          16 
HepB3          93  91  93  93  94 
Hib3          93  93  93  94  94 
JapEnc         
MCV1          93  93  93  94  94  93 
MCV2          92  92  93  92  94  89 
MenA         
PCV1         
PCV2         
PCV3         
Pol3          93  93  93  94  94  93 
Rota1          88  67  61 
RotaC          87  66  35 
RCV1          93  93  93  94  94 
TT2plus         
PAB         
VAD1         
YFV         
* indicates the country reported above 100% coverage.

  Next update: Mid-July 2018

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Estonia)
BCG
ChartChart
  95  95  95  96  97  99 
DTP1
ChartChart
  94  94  95  96  96  96 
DTP3
ChartChart
  93  93  93  94  94  93 
HepB3
ChartChart
  93  91  93  93  94 
HepB_BD
ChartChart
 
Hib3
ChartChart
  93  93  93  94  94 
MCV1
ChartChart
  93  93  93  94  94  93 
MCV2
ChartChart
  92  92  93  92  94  89 
PCV3
 
Pol3
ChartChart
  93  93  93  94  94  93 
RCV1
ChartChart
  93  93  93  94  94  93 
RotaC
ChartChart
  85  64  32 

Click for WHO-UNICEF coverage estimates data for PAB time series.

Number of districts in the country 15  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 93
From 80 to 89% 7
From 50 to 79% 0
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
0
DTP3 reported coverageDTP3 reported coverage

Immunization Schedule (2016 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG 1-5 days; Yes
DT 3, 4.5, 6 months; 2, 6-7 years; Yes children with contraindication to pertussis component
DTaPHibHepIPV Yes From January 2018
DTaPHibIPV 3, 4.5, 6 months; 2 years; Yes
DTaPIPV 6-7 years; Yes
HepB_Pediatric birth; 1, 6 months; Yes or 12 years; +1, +6 months;
Hib 3, 4.5, 6 months; 2 years; Yes children with contraindication to pertussis component
HPV Yes From January 2018
Influenza_Adult >= 65 years; and pregnant women, adults with chronic diseases, health care workers, Haj and travelers and other risk groups
Influenza_Pediatric 0-4 years; Yes and children with chronic diseases
IPV 3, 4.5, 6 months; 2, 6-7 years; Yes children with contraindication to pertussis component or above Y14 if incomplete vaccination
MMR 1, 13 years; Yes
Rabies Yes pre and post-exposure prevention
Rotavirus 2, 3, 4.5 months; Yes
Td 25 years; Yes every 10 years; children with contrindication to pertussis component and children > 14 years with uncomplete vaccination schedule and post-trauma vaccination
Tdap 15-16 years; Yes

Immunizaton indicators

Indicator Expected answer 2016  2015  2014  2013  2012  2011  2010 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2017-2018  2015-2016  2015-2016  2013-2014  2013-2014  2011-2013  2011-2013 
Nº of districts with microplans that include activities to raise immunization coverage number 15  15  15  15  15  15  16 

System performance

Total Nº districts in country number 15  15  15  15  15  15  16 
Nº districts with DTP3 coverage >=80% number 15  15  15  15  15  15   
% of districts with DTP3 coverage >=80% From 0 to 100% 100  100  100  100  100  100   
Nº districts with measles (MCV1) coverage >=95% number 11  10  11   
% of districts with MCV1 coverage >=95% From 0 to 100% 53  40  60  73  67  73   

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes  Yes  Yes  Yes  Yes  Yes 
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Finance

% of Immunization expenditure financed, using Government funds? From 0 to 100% 100  100    100  100  100   

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Sources

 1  "The 2017 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2016, data for 2015
 3  "United Nations, Population Division. The World Population Prospects - the 2017 revision". New York, 2017.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.